4.7 Review

Glial function (and dysfunction) in the normal & ischemic brain

Journal

NEUROPHARMACOLOGY
Volume 134, Issue -, Pages 218-225

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2017.11.009

Keywords

Astrocytes; Microglia; Oligodendroglia; Ischemia; Intracerebral hemorrhage; Brain injury - responses

Funding

  1. NATIONAL CANCER INSTITUTE [P50CA211015] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE ON AGING [R13AG035492] Funding Source: NIH RePORTER
  3. NCI NIH HHS [P50 CA211015] Funding Source: Medline
  4. NIA NIH HHS [R13 AG035492] Funding Source: Medline

Ask authors/readers for more resources

Astrocytes are the most abundant cell type in the central nervous system (CNS). Once considered to be of fairly homogeneous phenotype throughout the brain and spinal cord, they are now understood to be heterogeneous in both structure and function. They are important in brain functions as diverse as ion and fluid balance in the interstitial space, contributing to integrity of the neurovascular unit (blood-brain barrier), neurotransmitter regulation, metabolism of energy substrates and possibly even axonal regeneration. After ischemic or hemorrhagic brain/spinal cord injury, formation of an astrocytic scar adjacent to the 'lesion' is a characteristic histopathologic feature, and this astrogliosis can be demonstrated by immunohistochemistry, usually using primary antibodies to glial fibrillary acidic protein (GFAP). Astrocytes interact with microglia and oligodendroglia in novel ways that will be discussed in this review. This article is part of the Special Issue entitled 'Cerebral Ischemia'. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available